| __timestamp | Apellis Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2908166 | 2917513 |
| Thursday, January 1, 2015 | 6356782 | 7878291 |
| Friday, January 1, 2016 | 4303743 | 8366794 |
| Sunday, January 1, 2017 | 10463151 | 6610381 |
| Monday, January 1, 2018 | 22639184 | 6556000 |
| Tuesday, January 1, 2019 | 67046483 | 6930000 |
| Wednesday, January 1, 2020 | 139401000 | 8758000 |
| Friday, January 1, 2021 | 176771000 | 10806000 |
| Saturday, January 1, 2022 | 277163000 | 9844000 |
| Sunday, January 1, 2023 | 500815000 | 13481000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. From 2014 to 2023, Apellis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have shown contrasting approaches. Apellis has seen a staggering increase in SG&A expenses, growing from approximately $2.9 million in 2014 to over $500 million in 2023, marking a growth of over 17,000%. In contrast, Soleno's SG&A expenses have remained relatively stable, increasing modestly from around $2.9 million to $13.5 million, a growth of about 360% over the same period. This stark difference highlights Apellis's aggressive expansion strategy, while Soleno maintains a more conservative approach. Understanding these trends provides valuable insights into each company's operational strategies and financial priorities, offering a glimpse into their future trajectories in the pharmaceutical industry.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Perrigo Company plc
SG&A Efficiency Analysis: Comparing Apellis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Soleno Therapeutics, Inc. or Iovance Biotherapeutics, Inc.
Soleno Therapeutics, Inc. vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights